コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 etic group B2, which are implicated in human neonatal meningitis.
2 to prevent oxidative burst for the onset of neonatal meningitis.
3 ia via CR3 and preventing PGE-2 formation in neonatal meningitis.
4 in newborn infants and the leading cause of neonatal meningitis.
5 streptococci (GBSs) are the leading cause of neonatal meningitis.
6 K1 is a major gram-negative organism causing neonatal meningitis.
7 with BBB endothelium and the pathogenesis of neonatal meningitis.
8 ropensity to initiate brain abscesses during neonatal meningitis.
9 nt of gram-negative bacillary meningitis and neonatal meningitis.
10 is an essential step in the pathogenesis of neonatal meningitis.
11 emia, and is the second most common cause of neonatal meningitis.
12 d apoptotic neuronal injury in this model of neonatal meningitis.
13 ate to neurotoxicity in this animal model of neonatal meningitis.
14 tiae cause about 35% of cases of early-onset neonatal meningitis.
15 including acute pyelonephritis, sepsis, and neonatal meningitis.
16 ccus (GBS) is currently the leading cause of neonatal meningitis.
17 ExPEC, including ExPEC associated with human neonatal meningitis and avian colibacillosis, than in co
18 ia coli K1 is responsible for 80% of E. coli neonatal meningitis and is a common pathogen in urinary
19 erapy targeting infections such as bacterial neonatal meningitis and is an important step for the con
20 B Streptococcus (GBS) is a leading cause of neonatal meningitis and sepsis and an important cause of
22 with group B Streptococcus, a major cause of neonatal meningitis, and demonstrated that inhibition of
23 s (GBS) is the most common bacterium causing neonatal meningitis, and neonatal GBS meningitis continu
25 ase, Streptococcus agalactiae, implicated in neonatal meningitis, and several oral commensal streptoc
26 neous group of pathogens, encompasses avian, neonatal meningitis, and uropathogenic E. coli strains.
27 h as Escherichia coli K1, a leading cause of neonatal meningitis associated with significant mortalit
30 o phage therapy model for studying bacterial neonatal meningitis based on Escherichia coli (E. coli)
32 e most common gram-negative organism causing neonatal meningitis, but the mechanism by which E. coli
33 most common gram-negative bacterium causing neonatal meningitis, but the mechanisms by which E. coli
34 s the leading gram-negative organism causing neonatal meningitis, but the microbial basis of E. coli
36 B Streptococcus (GBS), the leading cause of neonatal meningitis, can enter human brain microvascular
39 nt study examined a subset of ExPEC strains: neonatal meningitis E. coli (NMEC) strains and avian-pat
40 ouse sepsis model, despite carrying multiple neonatal meningitis E. coli (NMEC) virulence factors and
42 Streptococcus (GBS) is the leading cause of neonatal meningitis; however, the molecular mechanisms t
43 chia coli is the second most common cause of neonatal meningitis in full-term infants (herein NMEC) a
47 ion to advances in prevention and therapy of neonatal meningitis is our incomplete understanding of t
48 es ST95 invasive infection in a rat model of neonatal meningitis, leading to the disruption of intest
49 hypothesized to be altered before late-onset neonatal meningitis (LOM), analogous to late-onset sepsi
53 rains causing avian colibacillosis and human neonatal meningitis, urinary tract infections, and septi
54 APEC strains tested in a rat model of human neonatal meningitis were able to cause meningitis, demon
55 m that can cause a highly aggressive form of neonatal meningitis, which often progresses to establish
57 B Streptococcus (GBS)] is a leading cause of neonatal meningitis, with late-onset disease (LOD) occur